More than 2,000 drugs now in cancer immunotherapy race |  | LONDON (Reuters) - The race to develop new immunotherapy treatments against cancer has sparked an unprecedented explosion in the oncology drug pipeline, with more than 2,000 immune system-boosting agents now in development. |
|  |
|  |  | |  |  | Related Video |
|  | |  | |  |  |  |  |  | A quick-fix on the day's news delivered when you want it. Register Today |  |
|  |  |  | A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today |  |
|  | » » MORE NEWSLETTERS |  |
|